GenoFocus Inc (187420) — Cash Flow Reinvestment Rate

Latest as of December 2025: 7.15x

GenoFocus Inc (187420) has a Cash Flow Reinvestment Rate of 7.15x as of December 2025, reinvesting ₩2.06 Billion (capex ₩138.88 Million plus investments ₩-1.92 Billion) from operating cash flow of ₩288.09 Million. See GenoFocus Inc (187420) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

7.15x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.06 Billion
Capex + Investments

Operating Cash Flow

₩288.09 Million
KRW

Capital Expenditures

₩138.88 Million
KRW

GenoFocus Inc Cash Flow Reinvestment Rate (2015–2025)

Historical reinvestment intensity for GenoFocus Inc across 6 annual periods. For the full cash flow conversion analysis, see GenoFocus Inc cash conversion from operations.

Annual Cash Flow Reinvestment Rate for GenoFocus Inc (2015–2025)

Year-by-year capital reinvestment analysis for GenoFocus Inc. See GenoFocus Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 2.28x ₩8.00 Billion ₩3.50 Billion ₩1.08 Billion ▼ -8.4%
2024 2.49x ₩7.15 Billion ₩2.87 Billion ₩699.16 Million ▼ -75.3%
2018 10.10x ₩15.80 Billion ₩1.56 Billion ₩7.42 Billion ▼ -4.5%
2017 10.58x ₩14.43 Billion ₩1.36 Billion ₩2.06 Billion ▼ -85.6%
2016 73.60x ₩37.98 Billion ₩516.09 Million ₩5.46 Billion ▲ +2249.8%
2015 3.13x ₩8.94 Billion ₩2.85 Billion ₩8.14 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow